Profile of Fibroadenoma Mammae Patients at MRCCC Siloam Semanggi Hospital 2019-2020

Fibroadenoma mammae is a benign tumor in the breast that can grow in women aged 14-35 years. FAM has a solid mass with a rubbery consistency, is well-defined, and has low cellularity cells. FAM is classified as a benign tumor but can increase the risk of breast cancer by as much as 2.17 times. There are at least 10% of women in the world have FAM lumps. Jakarta Breast Center reported 1,971 out of 2,495 patients suffering from benign FAM tumors. FAM incidents are increasing yearly, and the concerns are often misinterpreted as malignancy. Until now, the cause of FAM cannot be known with certainty. Several risk factors have been identified, such as family genetics, age, hormones, radiation exposure, and contraceptive use. This study aims to determine the profile of FAM sufferers at the MRCCC Siloam Semanggi Hospital in 2019-2020. The research was conducted by total sampling method using anatomic pathology archives. Research on 131 patient records found that the largest age group occurred at 16-30 years, with as many as 68 patients (51.9%). Based on the location of the breast, most FAM lumps were found on the right side in 58 patients (44.3%), with the majority having one lump in 92 patients (70.2%). The most commonly found FAM was > 6cm in 52 patients (39.7%), with the most commonly found consistency being supple in 102 patients (77.9%), and all of them had clear boundaries in 131 patients (100%). Women with risks and suspicions of breast lumps are expected to do early detection with the BSE procedure.